Lipid-lowering treatment in the improvement of outcomes in patients with atherosclerotic cardiovascular disease and diabetes mellitus

Lipid-lowering treatment in the improvement of outcomes in patients with atherosclerotic cardiovascular disease and diabetes mellitus: The role of PCSK9 inhibitors

Research output: Contribution to journal › Article › peer-review

The resolution of Russian scientific expert council was adopted on September 28, 2018, Moscow.

Original language	English
Pages (from-to)	103-106
Number of pages	4
Journal	Russian Journal of Cardiology
Volume	23
Issue number	12
DOIs	https://doi.org/10.15829/1560-4071-2018-12-103-106
State	Published - 1 Jan 2018

Atherosclerotic cardiovascular diseases, Diabetes mellitus, Low-density lipoprotein cholesterol, PCSK9 inhibitors

ID: 38739826